IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Report: American Pacific considering sale?

1:37 PM MDT | October 4, 2013 | Vincent Valk

American Pacific (Las Vegas), the parent company of Ampac Fine Chemicals, is considering a sale of the whole company, according to a Reuters report. KeyBanc (Cleveland) is reportedly advising American Pacific on the matter, although the report did not mention any potential buyers. Ampac Fine Chemicals reported $44.2 million in sales and $5.8 million in profits in the company’s fiscal third-quarter. Ampac Fine Chemicals produces active pharmaceutical ingredients and pharma intermediates, for anti-viral, oncology and central nervous system drugs. American...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa